🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 13 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/08/2016 25,30 27,45 25,30 27,18 +6,50% 8,50% 2.395.900
02/08/2016 25,98 26,20 24,52 25,52 -1,51% 6,47% 2.460.000
01/08/2016 25,30 26,06 24,85 25,91 +2,49% 4,78% 2.125.600
29/07/2016 24,57 25,31 24,31 25,28 +2,51% 4,07% 2.069.300
28/07/2016 24,62 25,12 24,25 24,66 +0,16% 3,53% 1.497.700
27/07/2016 24,59 24,85 24,00 24,62 +1,15% 3,46% 1.617.700
26/07/2016 23,41 24,49 23,28 24,34 +2,83% 5,17% 2.031.700
25/07/2016 24,03 24,07 23,34 23,67 -0,92% 3,04% 1.882.300
22/07/2016 22,91 24,48 22,61 23,89 +5,47% 8,16% 3.094.700
21/07/2016 22,52 23,41 22,33 22,65 +0,85% 4,80% 2.374.000
20/07/2016 20,86 22,61 20,30 22,46 +6,24% 11,07% 3.142.400
19/07/2016 21,20 21,73 21,01 21,14 +0,91% 3,40% 1.820.100
18/07/2016 20,93 21,50 20,42 20,95 +0,43% 5,16% 2.317.700
15/07/2016 20,23 20,91 19,71 20,86 +2,05% 5,93% 2.560.300
14/07/2016 21,40 21,52 20,08 20,44 -4,17% 6,73% 2.672.700
13/07/2016 22,30 22,48 20,79 21,33 -3,05% 7,58% 2.417.900
12/07/2016 21,50 22,44 21,02 22,00 +2,95% 6,60% 3.061.300
11/07/2016 22,60 22,75 21,31 21,37 -5,53% 6,37% 3.640.100
08/07/2016 20,77 22,80 20,75 22,62 +8,13% 9,87% 3.687.500
07/07/2016 20,94 21,20 20,45 20,92 +0,14% 3,58% 3.268.600
06/07/2016 20,10 21,18 19,92 20,89 +3,06% 6,27% 2.758.500
05/07/2016 19,96 20,75 19,47 20,27 +0,10% 6,41% 2.396.500
01/07/2016 19,08 20,37 19,06 20,25 +6,19% 6,87% 3.020.200
30/06/2016 18,56 19,30 18,29 19,07 +2,20% 5,44% 2.206.200
29/06/2016 17,88 18,74 17,64 18,66 +4,77% 6,15% 3.341.100
28/06/2016 17,05 17,89 17,05 17,81 +5,07% 4,93% 1.954.900
27/06/2016 18,22 18,75 16,65 16,95 -8,48% 11,53% 3.034.500
24/06/2016 17,07 18,88 17,00 18,52 +3,58% 11,01% 3.887.100
23/06/2016 17,31 18,10 17,03 17,88 +2,70% 6,18% 3.404.800
22/06/2016 16,86 18,04 16,52 17,41 +2,11% 9,02% 2.594.300